# OnCo record chugai (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/chugai/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "chugai" ;
  schema:name "Chugai Pharmaceutical"@en ;
  schema:alternateName "Chugai"@en, "中外製薬"@en ;
  schema:description "Chugai is a Tokyo pharmaceutical company majority-owned by Roche that discovered alectinib for ALK-positive lung cancer and sells Roche's cancer medicines in Japan."@en ;
  schema:url <https://onco.cc/companies/chugai/>, <https://www.chugai-pharm.co.jp/english/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Chugai> ;
  owl:sameAs <http://www.wikidata.org/entity/Q750619> ;
  schema:citation <https://www.chugai-pharm.co.jp/english/>, <https://clinicaltrials.gov/search?lead=Chugai%20Pharmaceutical>, <https://en.wikipedia.org/wiki/Chugai_Pharmaceutical_Co.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/alectinib/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/polatuzumab-vedotin/>, <https://onco.cc/drugs/lenograstim/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> .